F. Cetinkaya, Hatice Karagoz, Orhan Yıldız, Ic Hastaliklari Klinigi Kayseri Turkiye Acibadem Kayseri Hastanesi
{"title":"法匹拉韦与羟氯喹治疗COVID-19的肝脏安全性比较","authors":"F. Cetinkaya, Hatice Karagoz, Orhan Yıldız, Ic Hastaliklari Klinigi Kayseri Turkiye Acibadem Kayseri Hastanesi","doi":"10.5152/kd.2020.49","DOIUrl":null,"url":null,"abstract":"Objective: Since the first case from Wuhan, China in December 2019, COVID-19 has spread all over the world and a pandemic was declared by the World Health Organization on January 30, 2020 While there are no specific effective antiviral drugs or vaccines to treat or to prevent COVID-19;favipiravir, hydroxychloroquine and their combination are used in the treatment of COVID-19 in Turkey In this study, it was aimed to evaluate the demographic, clinical and laboratory findings, the treatments given and the effects of treatments on liver tests of the patients followed up with the diagnosis of COVID-19","PeriodicalId":17826,"journal":{"name":"Klimik Dergisi/Klimik Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Comparison of Liver Safety of Favipiravir and Hydroxychloroquine in COVID-19 Treatment\",\"authors\":\"F. Cetinkaya, Hatice Karagoz, Orhan Yıldız, Ic Hastaliklari Klinigi Kayseri Turkiye Acibadem Kayseri Hastanesi\",\"doi\":\"10.5152/kd.2020.49\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Since the first case from Wuhan, China in December 2019, COVID-19 has spread all over the world and a pandemic was declared by the World Health Organization on January 30, 2020 While there are no specific effective antiviral drugs or vaccines to treat or to prevent COVID-19;favipiravir, hydroxychloroquine and their combination are used in the treatment of COVID-19 in Turkey In this study, it was aimed to evaluate the demographic, clinical and laboratory findings, the treatments given and the effects of treatments on liver tests of the patients followed up with the diagnosis of COVID-19\",\"PeriodicalId\":17826,\"journal\":{\"name\":\"Klimik Dergisi/Klimik Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klimik Dergisi/Klimik Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5152/kd.2020.49\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klimik Dergisi/Klimik Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/kd.2020.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparison of Liver Safety of Favipiravir and Hydroxychloroquine in COVID-19 Treatment
Objective: Since the first case from Wuhan, China in December 2019, COVID-19 has spread all over the world and a pandemic was declared by the World Health Organization on January 30, 2020 While there are no specific effective antiviral drugs or vaccines to treat or to prevent COVID-19;favipiravir, hydroxychloroquine and their combination are used in the treatment of COVID-19 in Turkey In this study, it was aimed to evaluate the demographic, clinical and laboratory findings, the treatments given and the effects of treatments on liver tests of the patients followed up with the diagnosis of COVID-19
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
